We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

SemBioSys Obtains Rights to Platform-Enhancing Technologies from Syngenta

News   Jun 14, 2006

 
SemBioSys Obtains Rights to Platform-Enhancing Technologies from Syngenta
 
 
 

RELATED ARTICLES

Exposing and Exploiting Cancer’s Metabolic Addictions

News

Where a tumor arises dictates specific metabolic vulnerabilities, identifying potential targets for effective cancer treatments.

READ MORE

Gene Test for Breast Cancer Decreases Cost of Care Nationwide

News

A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million (about 2 percent of the overall costs in the first year).

READ MORE

Shining a Light on Rare Nerve Tumors

News

When a protein named "Merlin" fails to do its job, people can develop slow-growing, life-disrupting auditory nerve tumors that can disrupt their hearing and balance. Now scientists at Cincinnati Children's have discovered much more about how Merlin does its job – by working behind the scenes through a network of more than 50 other proteins.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE